AI-powered radiopharmaceutical trial finder to debut at EANM Congress 2024 in Hamburg
Summary: A new AI-powered tool called the "Radiopharmaceutical Trial Finder" will be showcased at the EANM Congress 2024 in Hamburg from October 20-22. Developed by WARMTH and Ancora.ai with funding from the ICPO Foundation, it aims to simplify access to clinical trials.
This platform allows patients and clinicians to quickly find relevant radiopharmaceutical trials based on specific needs. It sources real-time information from major clinical trial registries, enhancing collaboration among patients, researchers, and healthcare providers.
The tool represents a significant advancement in the field of radiopharmaceuticals, addressing challenges in trial discovery and promoting global research collaboration. It is designed to improve patient access to innovative treatments.
This is article metrics. Combined, they form a significance score, that indicates how important the news is on a scale from 0 to 10.
My algorithm scores 10,000 news articles daily, and creates a single significance-ordered list of news.
Read more about how I calculate significance, or see today's top ranked news on the main page:
See today's news rankings